Patents Assigned to Piramal Healthcare (Canada) Ltd
  • Publication number: 20160101214
    Abstract: The present invention relates to a minimally-invasive method for restoring a damaged or degenerated intevertebral disc at an early stage. The method comprises the step of administering an injectable in situ setting formulation in the nucleus pulposus of the damaged or degenerated disc of the patient. The formulation once injected combines with nucleus matters and host cells, and becomes viscous or gels in situ within the annulus fibrosus of the disc for increasing the thickness and volume of the damaged or degenerated disc. The formulation is retained within the disc for providing restoration of the damaged or degenerated disc.
    Type: Application
    Filed: December 17, 2015
    Publication date: April 14, 2016
    Applicant: PIRAMAL HEALTHCARE (CANADA) LTD.
    Inventors: Eric Andre DESROSIERS, Abdellatif CHENITE, Mohammed BERRADA, Cyril CHAPUT
  • Patent number: 8920842
    Abstract: The present invention relates a biopolymeric liquid aqueous composition for producing self-gelling systems and gels, which comprises: an acidic water-based medium, 0.1 to 10% by weight of a pH-gelling acid-soluble biopolymer; and 0.1 to 10% by weight of a water-soluble molecule having a basic character and a pKa between 6.0 and 8.4, or a water-soluble residue or sequence of the molecule having a basic character and a pKa between 6.0 and 8.4. The liquid composition has a final pH ranging from 5.8 and 7.4, and forms a stable solid and homogeneous gel within a temperature range from 10 to 70° C. The present invention also relates to a method for preparing the composition and uses thereof.
    Type: Grant
    Filed: October 9, 2009
    Date of Patent: December 30, 2014
    Assignee: Piramal Healthcare (Canada) Ltd.
    Inventors: Abdellatif Chenite, Cyril Chaput, Dong Wang, Amine Selmani
  • Patent number: 8747899
    Abstract: Self-forming hybrid compositions consisting in admixed liquid and solid components enable the formation of bio-materials. The present invention proposes a) a thermo-sensitive self-forming liquid component, being water-based and containing at least a polycationic polymer such as chitosan, and an organic mono-phosphate source, which is a solution at a pH ranging from 6.5 to 7.4; b) a solid component being mineral and composed of at least one of calcium, fluoride, strontium, carbonate and phosphate salts. Solid mineral salts preferentially have a recognized bioactive potential such as the calcium phosphate salts for bones. Both solid and liquid components are admixed to form an injectable liquid slurry or pre-gelled paste that turn in situ into a hybrid uniform gel-like bio-material.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: June 10, 2014
    Assignee: Piramal Healthcare (Canada) Ltd.
    Inventors: Cyril Chaput, Abdellatif Chenite
  • Patent number: 8389467
    Abstract: The present invention relates to self-setting compositions consisting in admixed liquid and solid components enable the formation of hardened bio-materials having a broad range of properties and performances. The present invention proposes a) a thermo-sensitive self-gelling liquid component, being water-based, comprising at least a polycationic and a phosphate source, wherein the liquid component is a thermo-gelling solution at a pH ranging from 6.5 to 7.4; b) a powder component consisting in at least two calcium phosphate sources. The preferred calcium phosphate source includes apatites, tricalcium phosphates, tetracalcium phosphates and dicalcium phosphates. Both solid and liquid components are admixed to form a flowable slurry that sets in situ into a hardened calcium phosphate based bio-material.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: March 5, 2013
    Assignee: Piramal Healthcare (Canada) Ltd.
    Inventors: Cyril Chaput, Anabelle Rodrigues El Zein
  • Patent number: 8258117
    Abstract: The present invention relates to a new method for repairing human or animal tissues such as cartilage, meniscus, ligament, tendon, bone, skin, cornea, periodontal tissues, abscesses, resected tumors, and ulcers. The method comprises the step of introducing into the tissue a temperature-dependent polymer gel composition such that the composition adhere to the tissue and promote support for cell proliferation for repairing the tissue. Other than a polymer, the composition preferably comprises a blood component such as whole blood, processed blood, venous blood, arterial blood, blood from bone, blood from bone-marrow, bone marrow, umbilical cord blood, placenta blood, erythrocytes, leukocytes, monocytes, platelets, fibrinogen, thrombin and platelet rich plasma. The present invention also relates to a new composition to be used with the method of the present invention.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: September 4, 2012
    Assignee: Piramal Healthcare (Canada) Ltd
    Inventors: Caroline D. Hoemann, Michael D. Buschmann, Marc D. McKee